
News
Advertisement


Advertisement




Advertisement


















Osteomyelitis a debilitating bone infection most frequently caused by Staphylococcus aureus bacteria is particularly challenging to treat. Now, Vanderbilt microbiologist Eric Skaar, PhD, MPH, and colleagues have identified a staph-killing compound that may be an effective treatment for osteomyelitis, and they have developed a new mouse model that will be useful for testing this compound and for generating additional therapeutic strategies.





Advertisement
Advertisement
Trending on Infection Control Today
1
TMVII Sexually Transmitted Ringworm: Symptoms, Diagnosis, Treatment, and Prevention
2
From Stockpile to Patient: Preparing Vaccine Delivery Before an Outbreak
3
The Next Generation of SPD Leadership: Human Plus Machine
4
The Next Generation of SPD Leadership: From the Basement to the Boardroom
5